Treatment of Metastatic Medullary Thyroid Cancer With Vandetanib: Need to Stratify Patients on Basis of Calcitonin Doubling Time Reply

Treatment of Metastatic Medullary Thyroid Cancer With Vandetanib: Need to Stratify Patients on Basis of Calcitonin Doubling Time Reply

Opis bibliograficzny
Główni autorzy:	Jr, W, Robinson, BG, Gagel, R, Dralle, H, Fagin, J, Santoro, M, Baudin, E, Elisei, R, Jarzab, B, Vasselli, JR, Read, J, Langmuir, P, Ryan, A, Schlumberger, M
Format:	Journal article
Wydane:	2012

Podobne zapisy

Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial.
od: Wells, SA, i wsp.
Wydane: (2012)

Reply to J.-F. Chatal et al.
od: Wells Jr, SA, i wsp.
Wydane: (2012)

Vandetanib for the Treatment of Metastatic Medullary Thyroid Cancer
od: Nils Degrauwe, i wsp.
Wydane: (2012-06-01)

Calcitonin receptor expression in medullary thyroid carcinoma
od: Virginia Cappagli, i wsp.
Wydane: (2017-09-01)

Phototoxic drug eruption induced by vandetanib used for the treatment of metastatic medullary thyroid cancer
od: Ecem Bostan, i wsp.
Wydane: (2022-09-01)

Evaluating vandetanib in the treatment of medullary thyroid cancer: patient-reported outcomes
od: Fallahi P, i wsp.
Wydane: (2019-08-01)

Efficacy of vandetanib in the treatment of medullary thyroid cancer: literature review and case report
od: А. М. Mudunov, i wsp.
Wydane: (2019-10-01)

CALCITONINS ROLE - REPLY
od: Kanis, J, i wsp.
Wydane: (1977)

Metastatic Medullary Thyroid Carcinoma with Normal Serum Calcitonin Levels
od: Tania Tofail, MRCP, i wsp.
Wydane: (2018-11-01)

Serum calcitonin negative Medullary thyroid carcinoma
od: Welsing Ellen, i wsp.
Wydane: (2006-12-01)

Effect of Vandetanib Treatment on Cystic Changes in the Liver following Metastasis from Medullary Thyroid Carcinoma
od: Ai Matsui, i wsp.
Wydane: (2022-01-01)

In-situ analysis of calcitonin and CGRP expression in medullary thyroid carcinoma.
od: Boultwood, J, i wsp.
Wydane: (1990)

Oncologic outcomes of calcitonin-negative medullary thyroid carcinoma
od: Wenliang Yue, i wsp.
Wydane: (2022-11-01)

Baseline VEGF as a potential predictive biomarker of vandetanib clinical benefit in patients with advanced NSCLC
od: Heymach, J, i wsp.
Wydane: (2008)

Efficacy of Vandetanib in Treating Locally Advanced or Metastatic Medullary Thyroid Carcinoma According to RECIST Criteria: A Systematic Review and Meta-Analysis
od: Pierpaolo Trimboli, i wsp.
Wydane: (2018-05-01)

Management of medullary thyroid cancer based on variation of carcinoembryonic antigen and calcitonin
od: Bo Wang, i wsp.
Wydane: (2024-10-01)

The role of calcitonin in the preoperative stage as the predictor of medullary thyroid cancer metastases
od: Volodymyr Palamarchuk, i wsp.
Wydane: (2021-12-01)

Kinase inhibitors for advanced medullary thyroid carcinoma
od: Martin Schlumberger, i wsp.
Wydane: (2012-01-01)

Medullary thyroid carcinoma and duodenal calcitonin-secreting neuroendocrine tumour: more than coincidence?
od: Huguet, I, i wsp.
Wydane: (2013)

Early calcitonin levels in medullary thyroid carcinoma: Prognostic role in patients without distant metastases at diagnosis
od: Clotilde Sparano, i wsp.
Wydane: (2023-02-01)

Time Kinetics and prognosis roles of calcitonin after surgery for medullary thyroid carcinoma
od: Fengli Guo, i wsp.
Wydane: (2024-05-01)

Progress of study on medullary thyroid carcinoma with serum calcitonin-negative and large mass
od: LI Rui, LIU Zhuoran, YAN Jiqi
Wydane: (2022-06-01)

Diagnostic Performance of Preoperative Calcitonin and Procalcitonin Tests for Differential Diagnosis of Medullary Thyroid Cancer
od: Il Youb Jeong, i wsp.
Wydane: (2024-08-01)

The neurotransmitter calcitonin gene-related peptide shapes an immunosuppressive microenvironment in medullary thyroid cancer
od: Yingtong Hou, i wsp.
Wydane: (2024-07-01)

Cytodiagnosis of medullary carcinoma thyroid- role of FNAC and serum calcitonin- A case report
od: Majed B Momin, i wsp.
Wydane: (2018-01-01)

False positive results using calcitonin as a screening method for medullary thyroid carcinoma
od: Rafael Loch Batista, i wsp.
Wydane: (2013-01-01)

Calcitonin negative Medullary Thyroid Carcinoma: a challenging diagnosis or a medical dilemma?
od: Claudio Gambardella, i wsp.
Wydane: (2019-05-01)

Prognostic Value of Preoperative Serum Calcitonin Levels for Predicting the Recurrence of Medullary Thyroid Carcinoma
od: Hyunju Park, i wsp.
Wydane: (2021-10-01)

Nephrotic Syndrome as a Complication of Systemic Calcitonin Amyloidosis From Long-Standing Metastatic Medullary Thyroid Cancer
od: Samantha M. Siskind, MD, i wsp.
Wydane: (2024-11-01)

Early postoperative calcitonin-to-preoperative calcitonin ratio as a predictive marker for structural recurrence in sporadic medullary thyroid cancer: A retrospective study
od: Zan Jiao, i wsp.
Wydane: (2022-12-01)

Baseline vascular endothelial growth factor concentration as a potential predictive marker of benefit from vandetanib in non-small cell lung cancer.
od: Hanrahan, E, i wsp.
Wydane: (2009)

Calcitonin testing in patients with thyroid nodules for screening medullary thyroid carcinoma: a “gray zone”
od: N. V. Severskaya, i wsp.
Wydane: (2022-08-01)

Selective use of vandetanib in the treatment of thyroid cancer
od: Fallahi P, i wsp.
Wydane: (2015-07-01)

Biophysical and computational characterization of vandetanib–lysozyme interaction
od: Kabir, Md Zahirul, i wsp.
Wydane: (2018)

Investigating the effect of vandetanib and celecoxib combination on angiogenesis
od: Abdul Qadir, MPhil, i wsp.
Wydane: (2023-10-01)

Dermoscopic findings of perifollicular pigmentation associated with vandetanib
od: Jade Cury-Martins, i wsp.
Wydane: (2018-10-01)

Analysis of treatment outcomes in patients with progressive locally advanced non-resectable and disseminated medullary thyroid cancer receiving vandetanib outside of clinical trials (Russian experience)
od: I. S. Romanov, i wsp.
Wydane: (2020-07-01)

Vandetanib in a Child Affected by Neurofibromatosis Type 1 and Medullary Thyroid Carcinoma with Both NF1 and Homozygous RET Proto-oncogen Germ-line Mutations
od: Begümhan Demir Gündoğan, i wsp.
Wydane: (2021-09-01)

Measurement of calcitonin and cea in the needle washout fluid from thyroid nodule for the diagnosis of medullary thyroid carcinoma
od: N. V. Severskaya, i wsp.
Wydane: (2023-11-01)

Lymph Node Metastases of Medullary Thyroid Cancer: Role of Calcitonin in the Washout Fluid of Fine-Needle Aspiration
od: Bernardo Marques, i wsp.
Wydane: (2020-01-01)